Effect of Topical Silver Nanoparticle Formulation on Wound Bacteria Clearance and Healing in Patients With Infected Wounds Compared to Standard Topical Antibiotic Application: A Randomized Open-Label Parallel Clinical Trial

• Published in: Curēus (Palo Alto, CA) Vol. 16; no. 5; p. e60569
• Main Authors: Pathi, Basanti K, Mishra, Subrajit, Moharana, Niranjan, Kanungo, Abinash, Mishra, Amaresh, Sahu, Subrat, Dash, Rajesh K, Dubey, Rajan, Das, Manoja K
• Format: Journal Article
• Language: English
• Published: United States Cureus Inc 18-05-2024; Cureus
• Subjects: Antibiotics; Antimicrobial agents; Bacteria; Bacterial infections; Clinical trials; Consent; Drug resistance; Ethics; Gender; General Surgery; Hospitals; Infections; Infectious Disease; Nanoparticles; Patients; Polyethylene glycol; Silver; Surgeons; Trauma; Wound healing; United States > US; India; silver nanoparticle; wound care treatment; wound healing; bacteria clearence; antibiotic sparing
• ISSN: 2168-8184; 2168-8184
• DOI: 10.7759/cureus.60569

Infected wounds pose a special challenge for management, with an increased risk of wound chronicity, systemic infection, and the emergence of antibiotic resistance. Silver nanoparticles have multimodal effects on bacteria clearance and wound healing. This study aimed to document the efficacy of a topical silver nanoparticle-based cream on bacteria clearance and wound healing in infected wounds compared to Mupirocin.
This open-label parallel randomized clinical trial allocated 86 participants with infected wounds (culture-positive) into Kadermin, silver nanoparticle-based cream arm (n=43) and Mupirocin arm (n=43) and documented the swab culture on day 5 and wound healing at day 28, along with periodic wound status using the Bates-Jensen Wound Assessment Tool. Patients received oral/systemic antibiotics and other medications for underlying diseases. The intention-to-treat principle was adopted for data analysis using the chi-square and Student t tests to document the differences between groups according to variable characteristics.
All participants completed the follow-up. On day 5, wound bacteria clearance was observed in 86% and 65.1% of the participants in the Kadermin and Mupirocin arms, respectively (p=0.023). At day 28, complete wound healing was observed in 81.4% and 37.2% of the participants in the Kadermin and Mupirocin arms, respectively (p≤0.001). No local or systemic adverse event or local reaction was observed in any of the participants.
Kadermin, the silver nanoparticle-based cream, has better efficacy in achieving faster wound bacteria clearance and healing in infected wounds compared to Mupirocin. This may have relevance for its use as an antibiotic-sparing agent in wound management.